A patient presented with a platelet count of 700 x 109/L with abnormalities in size, shape and granularity of platelets. WBC count of 8 x109 L, hemoglobin of 12 g/dl and the absence of the Philadelphia chromosome. The most likely diagnosis would be?
## **Core Concept**
The question describes a patient with thrombocytosis (elevated platelet count) and abnormalities in platelet morphology, along with a normal white blood cell (WBC) count, a normal hemoglobin level, and the absence of the Philadelphia chromosome. This presentation suggests a myeloproliferative neoplasm (MPN).
## **Why the Correct Answer is Right**
The patient's presentation of thrombocytosis with platelet morphology abnormalities, such as variations in size, shape, and granularity, is indicative of a myeloproliferative neoplasm. The absence of the Philadelphia chromosome helps to narrow down the diagnosis. The Philadelphia chromosome is commonly associated with chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL). Its absence makes CML less likely. Among the MPNs, **Essential Thrombocythemia (ET)** is characterized by marked thrombocytosis, often with abnormal platelet morphology, and the absence of the Philadelphia chromosome.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, A would be incorrect based on the information given and the typical diagnostic criteria for the conditions listed.
- **Option B:** Without the specific option provided, we can infer that any condition listed that does not match the clinical picture of ET or another MPN without the Philadelphia chromosome would be incorrect.
- **Option C:** Similarly, without specifics, if this option does not align with ET or another appropriate MPN, it would be incorrect.
- **Option D:** Assuming this is not the correct answer, if it suggests a condition like CML (which would typically have the Philadelphia chromosome), Polycythemia Vera (PV) without mention of erythrocytosis, or Primary Myelofibrosis (PMF) without mention of significant fibrosis, it would be incorrect.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **absence of the Philadelphia chromosome** is crucial in differentiating between certain myeloproliferative neoplasms, notably making CML less likely. Essential Thrombocythemia (ET) is a diagnosis of exclusion and requires the presence of thrombocytosis, the absence of the Philadelphia chromosome, and the exclusion of other causes of thrombocytosis.
## **Correct Answer:** C. Essential Thrombocythemia.